Viewing StudyNCT05055232



Ignite Creation Date: 2024-05-06 @ 4:40 PM
Last Modification Date: 2024-10-26 @ 2:14 PM
Study NCT ID: NCT05055232
Status: UNKNOWN
Last Update Posted: 2021-09-24
First Post: 2021-09-14

Brief Title: A Phase I Study of XZP-3621 in Chinese Patients With ALK or ROS1 Rearrangement Non-small Cell Lung Cancer
Sponsor: Xuanzhu Biopharmaceutical Co Ltd
Organization: Xuanzhu Biopharmaceutical Co Ltd

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-03-12
Start Date Type: ACTUAL
Primary Completion Date: 2023-03-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2023-09-12
Completion Date Type: ESTIMATED
First Submit Date: 2021-09-14
First Submit QC Date: September 14 2021
Study First Post Date: 2021-09-24
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-09-14
Last Update Post Date: 2021-09-24
Last Update Post Date Type: ACTUAL